IBDEI161 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20848,1,1,0)
 ;;=1^206.11
 ;;^UTILITY(U,$J,358.3,20848,1,8,0)
 ;;=8^Chr Monocytic Leuk in Remission
 ;;^UTILITY(U,$J,358.3,20848,2)
 ;;=^267546
 ;;^UTILITY(U,$J,358.3,20849,0)
 ;;=206.12^^118^1255^13
 ;;^UTILITY(U,$J,358.3,20849,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20849,1,1,0)
 ;;=1^206.12
 ;;^UTILITY(U,$J,358.3,20849,1,8,0)
 ;;=8^Chr Monocytic Leuk in Relapse
 ;;^UTILITY(U,$J,358.3,20849,2)
 ;;=^336477
 ;;^UTILITY(U,$J,358.3,20850,0)
 ;;=206.20^^118^1255^55
 ;;^UTILITY(U,$J,358.3,20850,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20850,1,1,0)
 ;;=1^206.20
 ;;^UTILITY(U,$J,358.3,20850,1,8,0)
 ;;=8^Subacute Monocytic Leuk w/o Remiss
 ;;^UTILITY(U,$J,358.3,20850,2)
 ;;=^336863
 ;;^UTILITY(U,$J,358.3,20851,0)
 ;;=206.21^^118^1255^54
 ;;^UTILITY(U,$J,358.3,20851,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20851,1,1,0)
 ;;=1^206.21
 ;;^UTILITY(U,$J,358.3,20851,1,8,0)
 ;;=8^Subacute Monocytic Leuk in Relapse
 ;;^UTILITY(U,$J,358.3,20851,2)
 ;;=^267548
 ;;^UTILITY(U,$J,358.3,20852,0)
 ;;=206.22^^118^1255^56
 ;;^UTILITY(U,$J,358.3,20852,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20852,1,1,0)
 ;;=1^206.22
 ;;^UTILITY(U,$J,358.3,20852,1,8,0)
 ;;=8^Subacute Monocytic Leuk w/o Remiss
 ;;^UTILITY(U,$J,358.3,20852,2)
 ;;=^336478
 ;;^UTILITY(U,$J,358.3,20853,0)
 ;;=206.80^^118^1255^41
 ;;^UTILITY(U,$J,358.3,20853,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20853,1,1,0)
 ;;=1^206.80
 ;;^UTILITY(U,$J,358.3,20853,1,8,0)
 ;;=8^Oth Monocytic Leuk w/ Remission
 ;;^UTILITY(U,$J,358.3,20853,2)
 ;;=^336864
 ;;^UTILITY(U,$J,358.3,20854,0)
 ;;=206.81^^118^1255^40
 ;;^UTILITY(U,$J,358.3,20854,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20854,1,1,0)
 ;;=1^206.81
 ;;^UTILITY(U,$J,358.3,20854,1,8,0)
 ;;=8^Oth Monocytic Leuk w/ Remiss
 ;;^UTILITY(U,$J,358.3,20854,2)
 ;;=^267551
 ;;^UTILITY(U,$J,358.3,20855,0)
 ;;=206.82^^118^1255^39
 ;;^UTILITY(U,$J,358.3,20855,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20855,1,1,0)
 ;;=1^206.82
 ;;^UTILITY(U,$J,358.3,20855,1,8,0)
 ;;=8^Oth Monocytic Leuk in Relapse
 ;;^UTILITY(U,$J,358.3,20855,2)
 ;;=^336479
 ;;^UTILITY(U,$J,358.3,20856,0)
 ;;=206.90^^118^1255^62
 ;;^UTILITY(U,$J,358.3,20856,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20856,1,1,0)
 ;;=1^206.90
 ;;^UTILITY(U,$J,358.3,20856,1,8,0)
 ;;=8^Unspec Monocytic Leuk w/o Remiss
 ;;^UTILITY(U,$J,358.3,20856,2)
 ;;=^336865
 ;;^UTILITY(U,$J,358.3,20857,0)
 ;;=206.91^^118^1255^61
 ;;^UTILITY(U,$J,358.3,20857,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20857,1,1,0)
 ;;=1^206.91
 ;;^UTILITY(U,$J,358.3,20857,1,8,0)
 ;;=8^Unspec Monocytic Leuk in Remiss
 ;;^UTILITY(U,$J,358.3,20857,2)
 ;;=^267554
 ;;^UTILITY(U,$J,358.3,20858,0)
 ;;=206.92^^118^1255^60
 ;;^UTILITY(U,$J,358.3,20858,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20858,1,1,0)
 ;;=1^206.92
 ;;^UTILITY(U,$J,358.3,20858,1,8,0)
 ;;=8^Unspec Monocytic Leuk in Relapse
 ;;^UTILITY(U,$J,358.3,20858,2)
 ;;=^336480
 ;;^UTILITY(U,$J,358.3,20859,0)
 ;;=207.00^^118^1255^3
 ;;^UTILITY(U,$J,358.3,20859,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20859,1,1,0)
 ;;=1^207.00
 ;;^UTILITY(U,$J,358.3,20859,1,8,0)
 ;;=8^AC Eryth & Erythroleuk w/o Remiss
 ;;^UTILITY(U,$J,358.3,20859,2)
 ;;=^336866
 ;;^UTILITY(U,$J,358.3,20860,0)
 ;;=207.01^^118^1255^1
 ;;^UTILITY(U,$J,358.3,20860,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20860,1,1,0)
 ;;=1^207.01
 ;;^UTILITY(U,$J,358.3,20860,1,8,0)
 ;;=8^AC Eryth & Erythroleuk in Relapse
 ;;^UTILITY(U,$J,358.3,20860,2)
 ;;=^267556
 ;;^UTILITY(U,$J,358.3,20861,0)
 ;;=207.02^^118^1255^2
 ;;^UTILITY(U,$J,358.3,20861,1,0)
 ;;=^358.31IA^8^2
